Department of Pediatric Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.
Biomed Res Int. 2020 Aug 26;2020:5843874. doi: 10.1155/2020/5843874. eCollection 2020.
Rhabdoid tumor of the kidney (RTK) is a rare and severely malignant tumor occurring in infancy and early childhood, with the overall outcomes remain poor. Neither gene regulatory networks nor biomarkers to predict the prognostic outcomes have been elucidated in RTK. In this study, RNA sequencing data were obtained to identify differentially expressed messenger RNAs (mRNAs), long noncoding RNAs (lncRNAs), and microRNAs (miRNAs) between RTK samples and normal samples. A total of 4217 mRNAs, 284 lncRNAs, and 286 miRNAs were screened out. Of those, 103 mRNAs, 80 lncRNAs, and 45 miRNAs were identified for a competing endogenous RNA (ceRNA) regulatory network, in which three significant modules were identified. A protein-protein interaction (PPI) network was constructed, and the hub-gene cluster consisted of four core genes (EXOSC2, PAK1IP1, WDR43, and POLR1D) was selected. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were also performed to analyze the functional characteristics of differentially expressed mRNAs. Subsequently, among 211 mRNAs, 8 lncRNAs, and 12 miRNAs associated with overall survival (OS) obtained by univariate Cox analysis, 5 mRNAs, 7 lncRNAs, and 7 miRNAs were identified and the risk score formulas were constructed correspondingly using the least absolute shrinkage and selection operator (LASSO) Cox regression model analysis. The log-rank tests and Kaplan-Meier analyses were performed to confirm the predictive value of the risk scores for OS in RTK patients. A genomic-clinicopathologic nomogram integrating the stage and risk scores based on RNAs was established and demonstrated high predictive accuracy and clinical value, which was validated through calibration curves, time-dependent receiver operating characteristic (ROC) curve analyses, and decision curve analysis (DCA). In conclusion, this study not only provided potential insights into the mechanisms underlying RTK, but also presented a practicable tool for predicting the prognosis in children with RTK.
肾横纹肌样瘤(RTK)是一种罕见且恶性程度极高的肿瘤,主要发生于婴幼儿,整体预后较差。目前尚未阐明 RTK 的基因调控网络或预测预后的生物标志物。本研究通过 RNA 测序数据,鉴定了 RTK 样本与正常样本之间差异表达的信使 RNA(mRNA)、长链非编码 RNA(lncRNA)和 microRNA(miRNA)。共筛选出 4217 个 mRNA、284 个 lncRNA 和 286 个 miRNA。其中,鉴定出 103 个 mRNA、80 个 lncRNA 和 45 个 miRNA 构建竞争内源性 RNA(ceRNA)调控网络,其中鉴定出 3 个显著模块。构建蛋白质-蛋白质相互作用(PPI)网络,选择包含 4 个核心基因(EXOSC2、PAK1IP1、WDR43 和 POLR1D)的核心基因簇。还进行了基因本体(GO)和京都基因与基因组百科全书(KEGG)通路富集分析,以分析差异表达 mRNA 的功能特征。随后,通过单因素 Cox 分析,从 211 个 mRNA、8 个 lncRNA 和 12 个 miRNA 中获得与总生存(OS)相关的结果,通过最小绝对值收缩和选择算子(LASSO)Cox 回归模型分析,分别鉴定出 5 个 mRNA、7 个 lncRNA 和 7 个 miRNA,并构建相应的风险评分公式。对数秩检验和 Kaplan-Meier 分析证实了风险评分对 RTK 患者 OS 的预测价值。建立了一个整合基于 RNA 的分期和风险评分的基因组-临床病理诺莫图,并通过校准曲线、时间依赖性接收者操作特征(ROC)曲线分析和决策曲线分析(DCA)验证了其具有较高的预测准确性和临床价值。总之,本研究不仅为 RTK 的发病机制提供了潜在的见解,还为预测 RTK 患儿的预后提供了一种可行的工具。